MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 208 filers reported holding MIRATI THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 1.52 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,259,470 | +21.6% | 51,871 | +0.8% | 0.00% | +50.0% |
| Q2 2023 | $1,858,780 | +103108.2% | 51,447 | +6.2% | 0.00% | 0.0% |
| Q1 2023 | $1,801 | -19.3% | 48,437 | -1.7% | 0.00% | -33.3% |
| Q4 2022 | $2,232 | -99.9% | 49,254 | +6.7% | 0.00% | -40.0% |
| Q3 2022 | $3,224,000 | +22.7% | 46,163 | +17.9% | 0.01% | +25.0% |
| Q2 2022 | $2,628,000 | -10.1% | 39,142 | +10.2% | 0.00% | 0.0% |
| Q1 2022 | $2,922,000 | -48.2% | 35,534 | -7.6% | 0.00% | -42.9% |
| Q4 2021 | $5,641,000 | -12.1% | 38,455 | +6.0% | 0.01% | -22.2% |
| Q3 2021 | $6,418,000 | +6.8% | 36,277 | -2.5% | 0.01% | +12.5% |
| Q2 2021 | $6,010,000 | -28.6% | 37,209 | -24.3% | 0.01% | -27.3% |
| Q1 2021 | $8,418,000 | -28.8% | 49,143 | -8.6% | 0.01% | -31.2% |
| Q4 2020 | $11,815,000 | +51.1% | 53,793 | +14.3% | 0.02% | +33.3% |
| Q3 2020 | $7,817,000 | +20.8% | 47,078 | -16.9% | 0.01% | +9.1% |
| Q2 2020 | $6,471,000 | +103.9% | 56,675 | +37.3% | 0.01% | +57.1% |
| Q1 2020 | $3,173,000 | -35.2% | 41,277 | +8.7% | 0.01% | -12.5% |
| Q4 2019 | $4,893,000 | +76.9% | 37,970 | +6.9% | 0.01% | +60.0% |
| Q3 2019 | $2,766,000 | -19.8% | 35,505 | +6.0% | 0.01% | -16.7% |
| Q2 2019 | $3,449,000 | +71.9% | 33,490 | +22.4% | 0.01% | +50.0% |
| Q1 2019 | $2,006,000 | +80.2% | 27,364 | +4.3% | 0.00% | +100.0% |
| Q4 2018 | $1,113,000 | +40.2% | 26,241 | +55.7% | 0.00% | 0.0% |
| Q3 2018 | $794,000 | -4.0% | 16,856 | +0.5% | 0.00% | 0.0% |
| Q2 2018 | $827,000 | +839.8% | 16,770 | -1.1% | 0.00% | – |
| Q1 2017 | $88,000 | +60.0% | 16,954 | +45.8% | 0.00% | – |
| Q4 2016 | $55,000 | -36.8% | 11,629 | -11.1% | 0.00% | – |
| Q3 2016 | $87,000 | +22.5% | 13,087 | +0.8% | 0.00% | – |
| Q2 2016 | $71,000 | -70.0% | 12,987 | +17.0% | 0.00% | -100.0% |
| Q1 2016 | $237,000 | -31.7% | 11,097 | +1.2% | 0.00% | 0.0% |
| Q4 2015 | $347,000 | +16.8% | 10,967 | +27.0% | 0.00% | 0.0% |
| Q3 2015 | $297,000 | +14.7% | 8,637 | +4.8% | 0.00% | 0.0% |
| Q2 2015 | $259,000 | – | 8,245 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |